Some Democrats have acknowledged that drug pricing legislation could slow development of new treatments in a shift in messaging. Some lawmakers have conceded that if drug prices are forced down, there could be fewer new drugs, but it’s a consequence they’re willing to accept. (STAT)

Vaping-related deaths have risen to 37, with 1,888 sickened. The Centers for Disease Control and Prevention have released weekly statistics on the outbreak showing the number of new cases is slowing. However, the CDC could not say if the outbreak has peaked. (Reuters)

The Federal Trade Commission is investigating Altria’s role in replacing Juul’s CEO. Last month, Juul’s founder and CEO stepped down and was replaced by Atria executive K.C. Crosthwaite. Altria holds a 35% stake in Juul that is awaiting antitrust approval from the FTC. (CNBC)

Optum has acquired patient-monitoring startup Vivify Health. The startup provides connected devices and other technology to track at-risk patients at home. Vivify joins other recent acquisitions by UnitedHealth, Optum’s parent company, including PatientsLikeMe and Equian. (CNBC)

Measles affects the body’s ability to fight other viruses even after it’s gone. New research showed that measles erases much of the immune system’s memory of how to fight other germs. It can take years to rebuild those defenses. (Associated Press)